WU CAPITAL
Wu Capital operates as an investment company. It invests in technology, media, telecom (TMT), healthcare, fintech, high-tech, offline experience consumptions, virtual experience consumptions, culture and Sports, and other related fields. Wu Capital operates business worldwide. It has its headquarters in Beijing in China.
WU CAPITAL
Social Links:
Industry:
Angel Investment FinTech Impact Investing Incubators Trading Platform Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
86 10 84899211
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS DigiCert SSL Pound Sterling Microsoft
Similar Organizations
Anova Capital
Anova Capital focus on investment in education, big health and new consumption.
Current Employees Featured
Rita Zhang
Rita Zhang CEO @ Wu Capital CEO
Yunpeng Xia
Yunpeng Xia Chief operating officer @ Wu Capital Chief operating officer
Martin Tian
Martin Tian Director of human resources @ Wu Capital Director of human resources
Alexa Zhang
Alexa Zhang Managing Director / Global Head of Fund Investing @ Wu Capital Managing Director / Global Head of Fund Investing 2020-01-01
Mingming Li
Mingming Li Chief Technology Officer @ Wu Capital Chief Technology Officer 2020-06-01
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-01-05 | Korro Bio | Wu Capital investment in Series B - Korro Bio | 116 M USD |
2021-09-23 | RiVAI | Wu Capital investment in Series A - RiVAI | N/A |
2021-08-19 | Ranok Therapeutics | Wu Capital investment in Series B - Ranok Therapeutics | 40 M USD |
2021-05-31 | Feiliu | Wu Capital investment in Series A - Feiliu | 200 M CNY |
2021-04-21 | Laiye | Wu Capital investment in Series C - Laiye | 50 M USD |
2021-02-08 | Gemini Therapeutics | Wu Capital investment in Post-IPO Equity - Gemini Therapeutics | 95 M USD |
2020-12-21 | Medbanks | Wu Capital investment in Series E - Medbanks | 305 M USD |
2020-11-11 | Inipharm | Wu Capital investment in Series A - Inipharm | 35 M USD |
2020-09-10 | Korro Bio | Wu Capital investment in Series A - Korro Bio | 91.5 M USD |
2020-07-13 | Citrine Medicine | Wu Capital investment in Series A - Citrine Medicine | 80 M USD |